What does Zwitserse Apotheek do?

Zwitserse Apotheek is a logistics company in Wijnegem. Private Limited, started on 1 January 1968, 1 establishment.

What is the address of Zwitserse Apotheek?

The registered office of Zwitserse Apotheek is located at Turnhoutsebaan 317, 2110 Wijnegem.

Is Zwitserse Apotheek still active?

Yes. According to the CBE (31 October 2026) Zwitserse Apotheek is active, legal situation “Normale toestand”, started on 1 January 1968.

Is Zwitserse Apotheek registered on Peppol?

Yes, Zwitserse Apotheek is registered on the Peppol network with ID 0208:0403785165.

What is the enterprise number of Zwitserse Apotheek?

The enterprise number of Zwitserse Apotheek is BE0403785165.

When was Zwitserse Apotheek founded?

Zwitserse Apotheek was founded on 1 January 1968.

Who are the directors of Zwitserse Apotheek?

According to the 2025 annual accounts, the directors of Zwitserse Apotheek are: PHARMALUX BV.

Is Zwitserse Apotheek a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1968; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Zwitserse Apotheek make in 2025?

Zwitserse Apotheek posted a profit after taxes of € 37,798 in financial year 2025.

What is the revenue of Zwitserse Apotheek?

As a small company, Zwitserse Apotheek is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 250,482.

How much does an employee at Zwitserse Apotheek earn?

The average wage cost per full-time employee at Zwitserse Apotheek was € 70,500 in 2025: staff costs of € 197,441 for 2.8 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Zwitserse Apotheek have?

According to the 2025 annual accounts, Zwitserse Apotheek has 2.8 full-time equivalents (FTE).

Zwitserse Apotheek (Private Limited) - Wijnegem

Dossier Zwitserse Apotheek, printed on 31 October 2026 from databakkes.be/en/0403785165/zwitserse-apotheek. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Shrinking team NBB

FTE fell two years in a row, from 3.8 to 2.8.

Financials

Financial year 2025

Zwitserse Apotheek from Wijnegem, company number BE0403785165, closed financial year 2025 with a result of € 37,798 after tax. For that financial year Zwitserse Apotheek recorded a gross margin of € 250,482 and equity of € 319,298. Compared with financial year 2024, the result moved from € -20,375 to € 37,798. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 27, 2026.

What it is worth Growing

€ 319,298

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 37,798

▲ still € 20,375 loss in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 260,626

▲ 24% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 300,706.

People and assets in 2025

Full-time equivalents

2.8

▼ 0.6 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 197,441

▼ 3% vs 2024

€ 70,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 217

▼ 79% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 65,954

▼ 10% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 25,747

▼ 2% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 279,169 Gross margin 2022: € 279,169 First fiscal year in the series	€ 197,360 Gross margin 2023: € 197,360 ▼ 29% vs 2022 (€ 279,169) Unfavourable step	€ 198,821 Gross margin 2024: € 198,821 ▲ 1% vs 2023 (€ 197,360) Favourable step	€ 250,482 Gross margin 2025: € 250,482 ▲ 26% vs 2024 (€ 198,821) Favourable step	▲ 26%
Profit after taxes	€ 42,413 Profit after taxes 2022: € 42,413 First fiscal year in the series	€ -27,498 Profit after taxes 2023: € -27,498 ▼ € 69,911 vs 2022 (€ 42,413) Unfavourable step	€ -20,375 Profit after taxes 2024: € -20,375 ▲ € 7,122 vs 2023 (€ -27,498) Favourable step	€ 37,798 Profit after taxes 2025: € 37,798 ▲ € 58,173 vs 2024 (€ -20,375) Favourable step	▲ € 58,173
Equity	€ 329,373 Equity 2022: € 329,373 First fiscal year in the series	€ 301,876 Equity 2023: € 301,876 ▼ 8% vs 2022 (€ 329,373) Unfavourable step	€ 281,500 Equity 2024: € 281,500 ▼ 7% vs 2023 (€ 301,876) Unfavourable step	€ 319,298 Equity 2025: € 319,298 ▲ 13% vs 2024 (€ 281,500) Favourable step	▲ 13%
Total debts	€ 205,835 Total debts 2022: € 205,835 First fiscal year in the series	€ 213,737 Total debts 2023: € 213,737 ▲ 4% vs 2022 (€ 205,835) Unfavourable step	€ 216,513 Total debts 2024: € 216,513 ▲ 1% vs 2023 (€ 213,737) Unfavourable step	€ 212,347 Total debts 2025: € 212,347 ▼ 2% vs 2024 (€ 216,513) Favourable step	▼ 2%
Cash	€ 237,293 Cash 2022: € 237,293 First fiscal year in the series	€ 218,922 Cash 2023: € 218,922 ▼ 8% vs 2022 (€ 237,293) Unfavourable step	€ 209,456 Cash 2024: € 209,456 ▼ 4% vs 2023 (€ 218,922) Unfavourable step	€ 260,626 Cash 2025: € 260,626 ▲ 24% vs 2024 (€ 209,456) Favourable step	▲ 24%
Retained profit	€ 310,781 Retained profit 2022: € 310,781 First fiscal year in the series	€ 283,284 Retained profit 2023: € 283,284 ▼ 9% vs 2022 (€ 310,781) Unfavourable step	€ 262,908 Retained profit 2024: € 262,908 ▼ 7% vs 2023 (€ 283,284) Unfavourable step	€ 300,706 Retained profit 2025: € 300,706 ▲ 14% vs 2024 (€ 262,908) Favourable step	▲ 14%
Balance sheet total	€ 535,209 Balance sheet total 2022: € 535,209 First fiscal year in the series	€ 515,613 Balance sheet total 2023: € 515,613 ▼ 4% vs 2022 (€ 535,209) Unchanged	€ 498,014 Balance sheet total 2024: € 498,014 ▼ 3% vs 2023 (€ 515,613) Unchanged	€ 531,646 Balance sheet total 2025: € 531,646 ▲ 7% vs 2024 (€ 498,014) Unchanged	▲ 7%
Employees (FTE)	3.8 Employees (FTE) 2022: 3.8 First fiscal year in the series	3.8 Employees (FTE) 2023: 3.8 Unchanged (3.8) Unchanged	3.4 Employees (FTE) 2024: 3.4 ▼ 0.4 vs 2023 (3.8) Unchanged	2.8 Employees (FTE) 2025: 2.8 ▼ 0.6 vs 2024 (3.4) Unchanged	▼ 0.6

Key figures of Zwitserse Apotheek, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Zwitserse Apotheek?

What happened at Zwitserse Apotheek in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 27, 2026 New annual accounts for financial year 2025: profit of € 37,798. Source: NBB ↗
2023 PHARMALUX BV became a director. NBB
Jan 1, 1968 Start of the company according to the CBE. KBO
Jul 1, 1961 New establishment in Wijnegem. KBO

In short

From € 42,413 profit in 2022 to € 37,798 profit in 2025.

Paid € 14,019 in corporate taxes since 2022.

Best year ever: 2022, with € 42,413 profit.

On average € 89,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

PHARMALUX 99.7%

The stake of PHARMALUX comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Zwitserse Apotheek

Behind Zwitserse Apotheek is PHARMALUX BV. The shares are held by PHARMALUX (99.7%).

Directors

According to the 2025 annual accounts

PHARMALUX BV

Director · represented by Hans Monstrey

Also active at: Bio-Homeopharma

since 2023

Shareholders

PHARMALUX

99.7%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Turnhoutsebaan 317

2110 Wijnegem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0403.785.165

VAT number

BE 0403.785.165

Registered office

Turnhoutsebaan 317, 2110 Wijnegem

Names & denominations

Zwitserse Apotheek · ZWITSERSE APOTEEK

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 January 1968

Peppol

Active · Active since 27 Mar 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗